The Government of Canada, as part of its overall supply management, and seeking to reduce logistics costs and rightsize inventories, was interested in either reducing or eliminating deliveries of Medicago doses. This occurred at the same time that Medicago was experiencing some challenges in achieving commercial-scale production.
On December 4th, 2023. See this statement in context.